Modeling how iso-caloric macronutrient substitutions are longitudinally associated with plasma kynurenines in colorectal cancer survivors up to 12 months post-treatment
Dietary intake of several macronutrients is associated with plasma kynurenines after colorectal cancer (CRC), and kynurenines have been linked to health-related outcomes. It is unknown how macronutrient substitution affects plasma kynurenines, which may be relevant for developing guidelines to improve post-CRC quality of life through dietary changes. Using iso-caloric substitution models, we investigated how substituting one macronutrient with another is longitudinally associated with plasma tryptophan, kynurenines, and kynurenine ratios in CRC survivors. Measurements were performed at 6-weeks, 6-months, and 12-months post-treatment in 247 stage I-III CRC survivors. Macronutrient intake was measured by 7-d dietary records and plasma kynurenines by LC/MS-MS. For analysis, we applied linear mixed models with false discovery rate (FDR) to adjust for multiple testing. After FDR adjustment, substituting 100 kcal/d of total carbohydrates with 100 kcal/d of total protein was associated with higher plasma concentrations of kynurenic acid (KA), xanthurenic acid (XA), and a higher kynurenic acid-to-quinolinic acid (KA/QA) ratio. Substituting 100 kcal/d of total carbohydrates with 100 kcal/d of total fat was associated with higher tryptophan concentrations, higher KA/QA ratio, and a lower kynurenine-to-tryptophan ratio (KTR) and hydroxykynurenine ratio (HKr). Substituting 100 kcal/d of total fat with 100 kcal/d of total protein was associated with higher XA concentrations. Altogether, iso-caloric macronutrient substitutions, particularly substituting carbohydrates with protein or fat, were longitudinally associated with higher concentrations of potentially favourable kynurenines and ratios (i.e., KA, XA, and KA/QA ratio) and lower ratios with pro-inflammatory or neurotoxic properties (i.e., KTR and HKr) in CRC survivors up to 12-months post-treatment.
Authors
- Stefanie Brezina (ORCID: https://orcid.org/0000-0001-5238-6900)
- Adrian McCann (ORCID: https://orcid.org/0000-0002-5728-5321)
- Dieuwertje E. Kok (ORCID: https://orcid.org/0000-0001-7154-8207)
- Martijn J.L. Bours (ORCID: https://orcid.org/0000-0002-5558-1258)
- Maryska L.G. Janssen‐Heijnen (ORCID: https://orcid.org/0000-0003-3575-6070)
- Per Magne Ueland (ORCID: https://orcid.org/0000-0002-1903-0571)
- Matty P. Weijenberg (ORCID: https://orcid.org/0000-0003-1695-4768)
- Daniëlle D. B. Holthuijsen (ORCID: https://orcid.org/0000-0002-4352-6198)
- Stéphanie O. Breukink (ORCID: https://orcid.org/0000-0002-5445-4011)
- Biljana Gigic (ORCID: https://orcid.org/0000-0002-8085-2072)
- Joop Konsten (ORCID: https://orcid.org/0000-0002-8803-1914)
- Eric T.P. Keulen (ORCID: https://orcid.org/0000-0001-6666-8773)
- Simone J. P. M. Eussen (ORCID: https://orcid.org/0000-0003-0559-6838)
- Eline H. van Roekel (ORCID: https://orcid.org/0000-0002-9402-2029)
- Cornelia M. Ulrich
Institutions
- University of Utah (US)
- Heidelberg University (DE)
- Maastricht University Medical Centre (NL)
- Huntsman Cancer Institute (US)
- University Hospital Heidelberg (DE)
- Maastricht University (NL)
- Comprehensive Cancer Center Vienna (AT)
- VieCuri Medisch Centrum (NL)
- Zuyderland Medisch Centrum (NL)
- Bevital (Norway) (NO)
- Medical University of Vienna (AT)
- Wageningen University & Research (NL)
Publication Details
- Journal
- The Journal of Nutritional Biochemistry
- Published
- 2025-03-31
- DOI
- https://doi.org/10.1016/j.jnutbio.2025.109910
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- World Cancer Research Fund International
- Health Foundation Limburg
- Universiteit Maastricht
- Bundesministerium für Bildung und Forschung
- Wereld Kanker Onderzoek Fonds
- National Institutes of Health
- World Cancer Research Fund
- National Cancer Institute